Bio Gene financial indicator trend analysis is way more than just evaluating Bio Gene Technology prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Bio Gene Technology is a good investment. Please check the relationship between Bio Gene Accounts Payable and its Total Current Liabilities accounts. Check out
Trending Equities to better understand how to build diversified portfolios, which includes a position in Bio Gene Technology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in board of governors.
Accounts Payable vs Total Current Liabilities
Accounts Payable vs Total Current Liabilities Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Bio Gene Technology Accounts Payable account and
Total Current Liabilities. At this time, the significance of the direction appears to have strong relationship.
The correlation between Bio Gene's Accounts Payable and Total Current Liabilities is 0.76. Overlapping area represents the amount of variation of Accounts Payable that can explain the historical movement of Total Current Liabilities in the same time period over historical financial statements of Bio Gene Technology, assuming nothing else is changed. The correlation between historical values of Bio Gene's Accounts Payable and Total Current Liabilities is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Accounts Payable of Bio Gene Technology are associated (or correlated) with its Total Current Liabilities. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Current Liabilities has no effect on the direction of Accounts Payable i.e., Bio Gene's Accounts Payable and Total Current Liabilities go up and down completely randomly.
Correlation Coefficient | 0.76 |
| Relationship Direction | Positive |
| Relationship Strength | Significant |
Accounts Payable
An accounting item on the balance sheet that represents Bio Gene obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Bio Gene Technology are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.
Total Current Liabilities
Total Current Liabilities is an item on Bio Gene balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Bio Gene Technology are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.
Most indicators from Bio Gene's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Bio Gene Technology current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Trending Equities to better understand how to build diversified portfolios, which includes a position in Bio Gene Technology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in board of governors.
Selling General Administrative is likely to gain to about 1.5
M in 2024, whereas
Issuance Of Capital Stock is likely to drop slightly above 2.2
M in 2024.
Bio Gene fundamental ratios Correlations
Click cells to compare fundamentals
Bio Gene Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Bio Gene fundamental ratios Accounts
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Additional Tools for Bio Stock Analysis
When running Bio Gene's price analysis, check to
measure Bio Gene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bio Gene is operating at the current time. Most of Bio Gene's value examination focuses on studying past and present price action to
predict the probability of Bio Gene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bio Gene's price. Additionally, you may evaluate how the addition of Bio Gene to your portfolios can decrease your overall portfolio volatility.